在两个单基因物种的基因组中识别潜在的药物标
V H Caña-Bozada1, C Ovando-Vázquez2,3, L C Flores-Méndez1,4
1Centro de Investigación en Alimentación y Desarrollo, A.C., Mazatlán, Sinaloa 82112, Mexico.
Helminthologia
|July 23, 2024
概括
研究人员鉴定和分类了单种寄生虫Rhabdosynochus viridisi和Scutogyrus longicornis中的蛋白激酶. 他们确定了潜在的单一性药物标 (MDT),并建议现有药物作为抗寄生虫剂重新使用.
科学领域:
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白激酶是细胞过程中的关键酶,是人类治疗的目标.
- 单种动物是鱼外寄生虫,在水产养殖业造成重大经济损失.
- 单基因的激酶谱系在很大程度上仍然没有被描述.
研究的目的:
- 鉴定和分类两个单基因物种中的蛋白质激酶,Rhabdosynochus viridisi和Scutogyrus longicornis.
- 使用计算方法预测潜在的单一性药物标 (MDTs).
- 为了确定现有的药物,这些药物可以重新作为抗单基因药物.
主要方法:
- 进行了转录组分析,以确定R. viridisi和S. longicornis中的酶基因.
- 在C. elegans致命的表型中具有正基因的基因酶,但在鱼类或人类中没有被指定为MDT.
- 分子对接被用来评估现有药物的结合 afinity 选择的MDTs.
主要成果:
- 在R. viridisi中发现了160个基因酶,在S. longicornis中发现了193个基因酶.
- 22个激酶被归类为MDT,主要来自CAMK,AGC和TK组.
- 狄欧戈他胺,欧戈他胺和洛米塔皮德对BRSK和MEKK1激酶具有很高的亲和力.
结论:
- 这项研究提供了R. viridisi和S. longicornis. 中酶的全面目录.
- 已识别的MDT和潜在的候选药物为开发新型抗单基因疗法提供了基础.
- 药物重新利用二欧戈他,欧戈他和洛米塔皮德为控制水产养殖中的单基因感染提供了一个有希望的途径.
相关概念视频
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


